期刊
BIOMARKERS IN MEDICINE
卷 6, 期 1, 页码 35-52出版社
FUTURE MEDICINE LTD
DOI: 10.2217/BMM.11.105
关键词
adipokine; atherosclerosis; biomarker; coronary artery disease; cytokine; C-reactive protein; diabetes mellitus; inflammation; metabolic syndrome; obesity
资金
- EU [HEALTH-F2-2009-223004]
- Interuniversity Cardiology Institute of the Netherlands (ICIN)
- Durrer Center for Cardiogenetic Research
- Netherlands Heart Foundation
- Center for Medical Systems Biology (CMSB)
- Netherlands Consortium for Healthy Ageing (NCHA)
Patients with obesity and diabetes mellitus are at increased risk for cardiovascular events and have a higher cardiovascular morbidity and mortality. This worse prognosis is partly explained by the late recognition of coronary heart disease in these patients, due to the absence of symptoms. Early identification of coronary heart disease is vital, to initiate preventive medical therapy and improve prognosis. At present, with the use of cardiovascular risk models, the identification of coronary heart disease in these patients remains inadequate. To this end, biomarkers should improve the early identification of patients at increased cardiovascular risk. The first part of this review describes the pathophysiologic pathway from obesity to coronary heart disease. The second part evaluates several mediators from this pathophysiologic pathway for their applicability as biomarkers for the identification of coronary heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据